LEGISLATIVE AND REGULATORY UPDATE
Week in Brief
Chronic Illness: Senate Finance Committee Chairman Orrin Hatch (R-UT) and Ranking Member Ranking Member Ron Wyden (D-OR) Release Joint Statement on Committee Passage of CHRONIC Care Act.
Medicaid Fraud: OIG Issues Medicaid Fraud Control Units FY 2016 Report.
Chronic Illness: Senate Finance Committee Conducts Hearing on CHRONIC Care Act of 2017. Senate Finance Committee Chairman Orrin Hatch (R-UT) Delivers Opening Statement at Hearing; Ranking Member Ron Wyden (D-OR) Also Speaks.
21st Century Cures: Senate HELP Committee Ranking Member Patty Murray (D-WA) and 10 Democratic Senators Send Letter to President Trump Regarding Proposed 18% Reduction to HHS Federal Civilian Workforce.
2018 NIH Budget Request: House Appropriations Subcommittee on Labor, HHS, Education, and Related Agencies Holds Oversight Hearing Titled, “Advances in Biomedical Research”. Subcommittee Ranking Member Rosa DeLauro (D-CT) Provides Opening Remarks.
FDA User Fees: House Energy and Commerce Committee Publishes Short Videos on FDA Reauthorization Act of 2017.
Public Health Initiatives: House Energy and Commerce Subcommittee on Health Conducts Legislative Hearing Titled, “Examining Initiatives to Advance Public Health”. House Energy and Commerce Committee Publishes Witness Summaries and Full Committee Chairman Greg Walden (R-OR) Statement; Ranking Member Frank Pallone Jr. (D-NJ) also Issues Remarks.
Tobacco Safety Standards: Energy and Commerce Ranking Member Frank Pallone, Jr. (D-NJ) and Health Subcommittee Ranking Member Gene Green (D-TX) Send Letter to FDA Commissioner Regarding FDA Implementation of Tobacco Regulation.
ACA: Senate Finance Committee Chairman Orrin Hatch (R-UT) Issues Statement on the Affordable Care Act.
Chronic Illness: Senate Finance Committee Holds Markup of the Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care (CHRONIC) Act of 2017. Senate Finance Committee Chairman Orrin Hatch (R-UT) Delivers Opening Remarks; Ranking Member Ron Wyden (D-OR) Also Speaks.
FDA User Fee Reauthorization: Energy and Commerce Subcommittee on Health Advances FDA User Fee Reauthorization Act of 2017; Congenital Heart Futures Reauthorization Act of 2017; and Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017.
Department of Health and Human Services
Cybersecurity: HHS Issues Update Regarding International Cyber Threat to Healthcare Organizations.
OIG: OIG Releases Report on HHS Adherence to the Improper Payment Information Act of 2002 for FY 2016.
State Waivers: CMS Publishes Checklist to Assist States in Seeking Section 1332 State Innovation Waivers.
Cybersecurity: HHS Issues Revised Update Regarding International Cyber Threats to Healthcare Organizations.
CPC+: CMS Announces Regions for Round 2 of the Comprehensive Primary Care Plus (CPC+) Model.
ACA Enrollment: CMS Announces New Enrollment Process for ACA Individual Market Coverage.
OIG: OIG Releases May 2017 Issue of “the Compendium of Unimplemented Recommendations.”
340B Program: HRSA Further Delays the Effective Date of the 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Final Rule.
Medicare: CMS Cements May 20, 2017 as the Effective Date of the “Advancing Care Coordination Through Episode Payment Models (EPMs); Cardiac Rehabilitation Incentive Payment Model; and Changes to the Comprehensive Care for Joint Replacement Model (CJR)” Final Rule. CMS Also Delays the Effective Date of Specific CJR Regulations.
House Energy and Commerce Subcommittee on Oversight and Investigation
U.S. Public Health Response to the Zika Virus: Continuing Challenges
• May 23 | 10:00 a.m.
2123 Rayburn House Office Building
Washington, DC 20515
House Committee on the Budget
The President’s Fiscal Year 2018 Budget
• May 24| 9:30 a.m.
1334 Longworth House Office Building
Washington, DC 20003
House Committee on Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Budget Hearing – Food and Drug Administration
• May 25 | 10:00 a.m.
2363-A Rayburn House Office Building
Washington, DC 20515
For more information about this issue of Power Play: Washington Week in Review or more legislative and regulatory updates, contact the Powers Pyles Sutter & Verville Government Relations and Public Policy group at (202) 466-6550.